ArticleCancer research2026

Combined Inhibition of HRAS and MEK Induces Tumor Regression and Restores Myogenic Differentiation in HRAS-Mutant Rhabdomyosarcoma.

Patience Odeniyide et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.